Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary
L Assersohn, A R Norman, D Cunningham, et al.
Bone Marrow Transplantation
|
November 1, 1994
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia
A Zomas, J Mehta, R Powles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials
I Chau, A R Norman, D Cunningham, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 19, 2026
Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trial
T S Varghese, S Faithfull, A Frampton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
P Ross, A Norman, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials
M Trumper, P J Ross, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer
N C Tebbutt, A Norman, D Cunningham, et al.
British Journal of Cancer
|
January 14, 2015
Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression
M Zhu, R Tang, S Doshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
P Ross, M Nicolson, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2020
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G Argilés, J Tabernero, R Labianca, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary
L Assersohn, A R Norman, D Cunningham, et al.
Bone Marrow Transplantation
|
November 1, 1994
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia
A Zomas, J Mehta, R Powles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials
I Chau, A R Norman, D Cunningham, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 19, 2026
Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trial
T S Varghese, S Faithfull, A Frampton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
P Ross, A Norman, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials
M Trumper, P J Ross, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer
N C Tebbutt, A Norman, D Cunningham, et al.
British Journal of Cancer
|
January 14, 2015
Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression
M Zhu, R Tang, S Doshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
P Ross, M Nicolson, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2020
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G Argilés, J Tabernero, R Labianca, et al.
Page
of 4